BRIEF-EMA Says Preliminary Data Indicate Adapted mRNA Vaccines Could Increase Protection As Boosters

European Medicines Agency: * EMA - PRELIMINARY DATA INDICATE ADAPTED MRNA VACCINES, WHICH INCORPORATE AN OMICRON VARIANT STRAIN, CAN INCREASE, EXTEND PROTECTION, WHEN USED AS A BOOSTER

* EMA: BIVALENT MRNA VACCINE TARGETING TWO STRAINS OF SARS-COV-2, INCLUDING OMICRON STRAIN, MAY PROVIDE SOME ADVANTAGES IN WIDENING IMMUNE RESPONSE * EMA - SHOTS WHICH INCLUDE OTHER VARIANTS MIGHT ALSO BE CONSIDERED FOR USE AS BOOSTERS IF DATA SHOW ADEQUATE LEVEL OF NEUTRALISATION AGAINST OMICRON AND OTHERS

* EMA - BIVALENT VACCINES COULD BE CONSIDERED INITIALLY FOR USE AS BOOSTERS